HLA haploidentical hematopoietic stem cell transplantation, Phase II trial - haplo-SCT (Hyogo), Phase II

Hyogo College of Medicine0 sites100 target enrollmentJune 18, 2017

Conditionshematologic malignancies, bone marrow failure syndrome, and other hematological disorders which requires hematopoietic stem cell transplantation

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: hematologic malignancies, bone marrow failure syndrome, and other hematological disorders which requires hematopoietic stem cell transplantation
Sponsor: Hyogo College of Medicine
Enrollment: 100
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

June 18, 2017

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Hyogo College of Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\) allergic for drugs used in this protocol 2\) active CNS lesion (exclude original disease) 3\) active infection 4\) when the physician in chief decides the patient is inappropriate for this protocol

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Not Applicable

HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic diseasesAcute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Secondary acute myelogenous leukemia Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)

JPRN-UMIN000002069Hematology, Osaka City University, Graduate School of Medicine17

Completed

Phase 2

HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic malignancies (OCU13-3)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia (ALL) Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS)

JPRN-UMIN000011293Osaka City University35

Completed

Phase 2

HLA-haploidentical allogeneic stem cell transplantation for Adult T-cell leukemia/lymphoma (ATL/L) and refractory aggressive lymphomaAdult T-cell leukemia/lymphoma (acute type and lymphoma type) Malignant lymphoma (aggressive hodgkin and non-hodgkin lymphoma)

JPRN-UMIN000002606Hematology, Osaka City University, Graduate School of Medicine17

Completed

Phase 1

Haploidentical hematopoietic stem cell transplantation in combination with posttransplant cyclophosphamide and ATG-thymoglobulin Phase I studyhematological malignancy

JPRN-UMIN000009374ational Cancer Center Hospital15

Completed

Phase 1

Haploidentical hematopoietic stem cell transplantation with posttransplant cyclophosphamide in combination with thymoglobulin (RIC version) Phase IHematological malignancy

JPRN-UMIN000011004ational Cancer Center Hospital12